Frank J. Broekmans

Reproductive Medicine · 2002–2018

A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Reproductive Medicine — 36 citations into it; #157 of 208 by trust here, #53 by citations
• Public Health, Environmental and Occupational Health — 34 citations into it; #2,175 of 2,368 by trust here, #1,184 by citations
• Pediatrics, Perinatology and Child Health — 7 citations into it

Whom Frank J. Broekmans trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. E. T. te Velde
2. A. Shelling
3. Michael Olivier
4. E. Riboli
5. Bart C. J. M. Fauser
6. J. Deeks
7. J. Laven
8. Joel Hirschhorn

Who trusts Frank J. Broekmans overall

1. Bart C. J. M. Fauser
2. S. Broer

Papers from Frank J. Broekmans's perspective

Ordered by how strongly the researchers Frank J. Broekmans trusts endorse each paper. Same corpus, a different order for every researcher.

1. The variability of female reproductive ageing. (Human Reproduction Update)
2. Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary. (Endocrinology)
3. Antimüllerian hormone serum levels: a putative marker for ovarian aging. (Fertility and Sterility)
4. Conducting systematic reviews of diagnostic studies: didactic guidelines (BMC Medical Research Methodology)
5. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. (Human Reproduction)
6. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. (British medical journal)
7. The diagnostic odds ratio: a single indicator of test performance. (Journal of Clinical Epidemiology)
8. Refining clinical diagnosis with likelihood ratios. (The Lancet)
9. [Structural variation in the human genome]. (Yi chuan = Hereditas)
10. A systematic review of tests predicting ovarian reserve and IVF outcome. (Human Reproduction Update)

Their papers

• Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018) — 2,461 citations
• The physiology and clinical utility of anti-Mullerian hormone in women. (2014) — 954 citations
• Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. (2014) — 608 citations
• Ovarian aging: mechanisms and clinical consequences. (2009) — 1,135 citations
• A systematic review of tests predicting ovarian reserve and IVF outcome. (2006) — 1,247 citations
• Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. (2002) — 1,017 citations